High levels of domestic transmission and drug resistance –analysis of national surveillance data for shigellosis, the Netherlands, 2018 to 2024
Boas van der Putten, Hendrik Sauskojus, Anouk Meijs, Daan Notermans, Maren Lanzl, Eelco Franz, Maaike van den Beld, Roan Pijnacker, on behalf of the ISIS-AR study group · 2026
Read High levels of domestic transmission and drug resistance –analysis of national surveillance data for shigellosis, the Netherlands, 2018 to 2024 by Boas van der Putten, Hendrik Sauskojus, Anouk Meijs, Daan Notermans, Maren Lanzl, Eelco Franz, Maaike van den Beld, Roan Pijnacker, on behalf of the ISIS-AR study group (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13675696.txt.
Description
Boas van der Putten and co-authors analyze, in 2026, national records on shigellosis in the Netherlands from 2018 to 2024. The illness spreads through the gut and is caused by Shigella bacteria. Drug resistance in these bacteria is rising, which makes close tracking urgent.
Over the seven years, 3,020 cases were reported to the national system. Gene-based tracking of the bacteria began in 2022, partway through the period. The team linked cases with age, sex, travel, place, illness severity, and bacterial species. Their models also weighed links with spread among men who have sex with men. The title finding is stark: much spread now happens at home, inside the country, and resistance is high. Health officials can use the results to aim control efforts.
Catalog record
| CREATOR | Boas van der Putten, Hendrik Sauskojus, Anouk Meijs, Daan Notermans, Maren Lanzl, Eelco Franz, Maaike van den Beld, Roan Pijnacker, on behalf of the ISIS-AR study group |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |